An Elective Course on Landmark Trials to Improve Pharmacy Students' Literature Evaluation and Therapeutic Application Skills

被引:8
作者
Burkiewicz, Jill S. [1 ]
Komperda, Kathy E. [1 ]
机构
[1] Midwestern Univ, Chicago Coll Pharm, Downers Grove, IL 60515 USA
关键词
elective course; evidence-based medicine; literature evaluation; EVIDENCE-BASED MEDICINE; LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION;
D O I
10.5688/aj730231
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objectives. To determine the impact of a landmark trials elective course on pharmacy students' attitudes toward evidence-based medicine, students' comfort with technical concepts used in drug literature, and students' perceptions of accessibility of PubMed from home computers. Design. An elective course which gave third-year pharmacy students the opportunity to discuss landmark trials in primary care and reinforced skills in applying evidence from the primary literature to support therapeutic recommendations was design and implemented. The impact of the course was evaluated via a pre- and postcourse questionnaire administered during 3 consecutive course offerings. Assessment. Overall, students had positive attitudes toward evidence-based medicine before taking the course (97.5% positive or somewhat positive) and these attitudes were unchanged postcourse (p = 0.74). Though 97.6% (n = 40) of students had Internet access at home, only 68.3% (n = 28) indicated having PubMed access at home. The course increased self-assessed comfort with technical concepts used in literature evaluation including random assignment (p < 0.01), placebo-controlled (p < 0.01), and intention-to-treat (p = 0.02). Conclusion. An elective course on landmark trials allowed third-year pharmacy students to increase their comfort level with literature evaluation and reinforced their positive attitudes toward the use of evidence-based medicine in pharmacy practice.
引用
收藏
页数:7
相关论文
共 27 条
[1]  
*AM ASS COLL PHARM, 2004, ADV PAN ED OUTC ED O
[2]  
[Anonymous], 1991, JAMA, V265, P3255
[3]  
[Anonymous], 2003, HLTH PROF ED BRIDG Q
[4]   Evidence-based practice by pharmacists: Utilization and barriers [J].
Burkiewicz, JS ;
Zgarrick, DP .
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) :1214-1219
[5]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[7]  
Collins R, 2003, LANCET, V361, P2005
[8]  
Dorsch JL, 2004, J MED LIBR ASSOC, V92, P397
[9]  
Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
[10]  
Gerstein HC, 2000, LANCET, V355, P253